Home » Authors » Anette Breindl

Articles by Anette Breindl

Researchers Link P53 Tumor Suppressor To Angiogenesis

Aug. 18, 2006

By Anette Breindl

Two Types Of Channel Blockers Could Be Faster Antidepressants

Aug. 15, 2006

By Anette Breindl

Two Types Of Channel Blockers Could Be Faster Antidepressants

Aug. 15, 2006

By Anette Breindl

NFkB Blamed For Exacerbating Multiple Sclerosis Inflammation

Aug. 14, 2006

By Anette Breindl

NFkB Blamed For Exacerbating Multiple Sclerosis Inflammation

Aug. 14, 2006

By Anette Breindl

Mouse Model May Help Better Quantify Gene Therapy Risks

Aug. 11, 2006

By Anette Breindl

Mouse Model May Help Better Quantify Gene Therapy Risks

Aug. 11, 2006

By Anette Breindl

CpGs Tweak Cells Toward Innate, Adaptive Immunity

Aug. 10, 2006

By Anette Breindl

CpGs Tweak Cells Toward Innate, Adaptive Immunity

Aug. 10, 2006

By Anette Breindl

Looking Beyond Infected T Cells For Anti-HIV Therapeutic Ammo

Aug. 7, 2006

By Anette Breindl

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...